490 filings
Page 5 of 25
6-K
u5jjd00dzv4rt bqt
20 May 21
Neovasc Provides Update on German Litigation
4:28pm
6-K
algq9 joq3y9h8jx
13 May 21
Current report (foreign)
2:29pm
6-K
iulvvxg693zu
10 May 21
Neovasc Announces First Patient Enrollment in COSIMA Trial
3:50pm
6-K
llbyw1c mab22g
6 May 21
Condensed Interim Consolidated Financial Statements
4:06pm
6-K
81cht0d0wa2j rc
6 May 21
Neovasc Announces First Quarter 2021 Financial Results
4:05pm
F-10/A
0lnz60t
4 May 21
Registration of securities (Canada) (amended)
6:31am
6-K
wnrza1ql px23a2ep
4 May 21
Form 51-102F3 Material Change Report
12:00am
6-K
1cq 8h7u7feyf
28 Apr 21
Neovasc Provides Reducer Reimbursement Progress Update
9:07am
6-K
7esc0c049 7msr48u5c4
27 Apr 21
Current report (foreign)
9:07am
6-K
plo5 6i84
19 Apr 21
Current report (foreign)
9:30am
F-X
2g934fg1wtdo ncy
16 Apr 21
Appointment of agent for service of process by issuers registering securities
2:11pm
F-10
v4blg4osiuw4b8qs01t
16 Apr 21
Registration of securities (Canada)
1:42pm
6-K
l9vxj2qj
16 Apr 21
Neovasc Provides Tiara TA Update
9:58am
40-F
h40l2x
11 Mar 21
Annual report (Canada)
4:44pm
6-K
lx20 f7p97etmexle8
11 Mar 21
Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results
4:07pm
6-K
4ge h4akn4
4 Mar 21
Current report (foreign)
9:03am
6-K
5jlzlkzbdwt6aq0un15h
3 Mar 21
Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference
4:57pm
6-K
b9aigarujis
2 Mar 21
Current report (foreign)
9:07am
6-K
wicda5g7bq23c botaj
24 Feb 21
Current report (foreign)
4:07pm
6-K
v0w8oh4hrww3pw2p8
23 Feb 21
FormĀ 51-102F3 Material Change Report
12:00am